tirzepatide glp-1 gip glp 1 and Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research The dual agonist action of
Description
The answer is always individual
A slower titration gives your digestive system time to adjust before the medication reaches therapeutic levels
It increases ghrelin (hunger hormone) by 15 to 28%
Or you might find clear evidence that your current dose is insufficient, giving you concrete data to bring to your escalation discussion
But securing coverage may be a long shot
